These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Ahman H; Käyhty H; Vuorela A; Leroy O; Eskola J Vaccine; 1999 Jun; 17(20-21):2726-32. PubMed ID: 10418924 [TBL] [Abstract][Full Text] [Related]
83. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis. Lee H; Hahn S; Lee HJ; Kim KH J Korean Med Sci; 2010 Jan; 25(1):90-6. PubMed ID: 20052353 [TBL] [Abstract][Full Text] [Related]
84. Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B. Anderson EL; Frey S; Geldmacher K; Radley D; Lee A; Donnelly J; Mendelman PM; Dargan JM; Kaplan KM Pediatr Infect Dis J; 2002 Apr; 21(4):350-2. PubMed ID: 12075771 [TBL] [Abstract][Full Text] [Related]
85. Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype. Lenoir AA; Pandey JP; Granoff DM J Infect Dis; 1988 Jun; 157(6):1242-5. PubMed ID: 3131441 [No Abstract] [Full Text] [Related]
86. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children. Eskola J; Takala AK; Käyhty H Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627 [TBL] [Abstract][Full Text] [Related]
87. Regulatory T cells in the antibody response to Haemophilus influenzae type b polysaccharide. Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ Infect Immun; 1999 Feb; 67(2):789-93. PubMed ID: 9916091 [TBL] [Abstract][Full Text] [Related]
89. Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly. Kantor E; Luxenberg JS; Lucas AH; Granoff DM Vaccine; 1997 Feb; 15(2):129-32. PubMed ID: 9066028 [TBL] [Abstract][Full Text] [Related]
90. Anticapsular polysaccharide IgG concentrations in Mexican children formerly immunized with Haemophilus influenzae b PRP-T vaccine. de León PG; Díaz García FJ; Arredondo JL; Segura J; Cerezo SG; Santos JI Hum Vaccin; 2007; 3(5):187-91. PubMed ID: 17643076 [TBL] [Abstract][Full Text] [Related]
91. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Barington T; Gyhrs A; Kristensen K; Heilmann C Infect Immun; 1994 Jan; 62(1):9-14. PubMed ID: 8262653 [TBL] [Abstract][Full Text] [Related]
92. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Schneerson R; Robbins JB; Chu C; Sutton A; Vann W; Vickers JC; London WT; Curfman B; Hardegree MC; Shiloach J Infect Immun; 1984 Sep; 45(3):582-91. PubMed ID: 6332076 [TBL] [Abstract][Full Text] [Related]
93. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose. Sood SK; Ballanco GA; Daum RS J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901 [No Abstract] [Full Text] [Related]
94. Immunogenicity of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer membrane protein complex conjugate vaccine in infants and children with sickle cell disease. Newcomer W; Santosham M; Bengston S; Panny S; Dover G Pediatr Infect Dis J; 1993 Dec; 12(12):1026-7. PubMed ID: 8108211 [No Abstract] [Full Text] [Related]
95. Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls. Avanzini MA; Carrà AM; Maccario R; Zecca M; Zecca G; Pession A; Comoli P; Bozzola M; Prete A; Esposito R; Bonetti F; Locatelli F J Clin Immunol; 1998 May; 18(3):193-201. PubMed ID: 9624578 [TBL] [Abstract][Full Text] [Related]
96. Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization. Singleton RJ; Davidson NM; Desmet IJ; Berner JE; Wainwright RB; Bulkow LR; Lilly CM; Siber GR Pediatr Infect Dis J; 1994 May; 13(5):362-7. PubMed ID: 8072817 [TBL] [Abstract][Full Text] [Related]
97. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Richmond P; Goldblatt D; Fusco PC; Fusco JD; Heron I; Clark S; Borrow R; Michon F Vaccine; 1999 Nov; 18(7-8):641-6. PubMed ID: 10547423 [TBL] [Abstract][Full Text] [Related]
98. [Specific antibodies in children with recurrent respiratory infections immunized with pneumo 23 and Act-HIB vaccines]. Foshina EP; Kostinov MP; Iastrebova NE Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):37-40. PubMed ID: 20795384 [TBL] [Abstract][Full Text] [Related]
99. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Pichichero ME Hum Vaccin Immunother; 2013 Dec; 9(12):2505-23. PubMed ID: 23955057 [TBL] [Abstract][Full Text] [Related]
100. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Schneerson R; Robbins JB; Parke JC; Bell C; Schlesselman JJ; Sutton A; Wang Z; Schiffman G; Karpas A; Shiloach J Infect Immun; 1986 May; 52(2):519-28. PubMed ID: 3516876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]